These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11695564)

  • 21. Decreased c-kit function inhibits enhanced skin carcinogenesis in c-Ha-ras protooncogene transgenic mice.
    Muto S; Katsuki M; Horie S
    Cancer Sci; 2007 Oct; 98(10):1549-56. PubMed ID: 17683512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative models for carcinogenicity testing: weight of evidence evaluations across models.
    Cohen SM
    Toxicol Pathol; 2001; 29 Suppl():183-90. PubMed ID: 11695556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation and overexpression of the transgene in ethylnitrosourea-induced tumors in mice carrying a human prototype c-Ha-ras gene.
    Toyosawa K; Tanaka K; Imai T; Yasuhara K; Koujitani T; Hirose M; Mitsumori K
    Toxicol Pathol; 2003; 31(5):491-5. PubMed ID: 14692617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice.
    Okamura M; Moto M; Kashida Y; Machida N; Mitsumori K
    Toxicol Pathol; 2004; 32(4):474-81. PubMed ID: 15223773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of modifying effects of eugenol on development of lung proliferative lesions induced by urethane in transgenic mice carrying the human prototype c-Ha-ras gene.
    Koujitani T; Yasuhara K; Tamura T; Onodera H; Takagi H; Takizawa T; Hirose M; Hayashi Y; Mitsumori K
    J Toxicol Sci; 2001 Aug; 26(3):129-39. PubMed ID: 11552296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 26-week Tg.rasH2 mice carcinogenicity studies: microscopic examination of only select tissues in low- and mid-dose groups.
    Paranjpe MG; Denton MD; Elbekai RH
    Toxicol Pathol; 2014 Oct; 42(7):1153-7. PubMed ID: 23960167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains.
    Ozaki M; Ozaki K; Watanabe T; Uwagawa S; Okuno Y; Shirai T
    Toxicol Pathol; 2005; 33(2):267-71. PubMed ID: 15902970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene.
    Ogawa K; Imaida K; Masui T; Kawabe M; Hasegawa R; Kato K; Ito N; Shirai T
    Carcinogenesis; 1996 Feb; 17(2):341-5. PubMed ID: 8625461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible mechanism on enhanced carcinogenesis of genotoxic carcinogens and unsolved mechanisms on lesser carcinogenic susceptibility to some carcinogens in rasH2 mice.
    Mitsumori K
    J Toxicol Sci; 2003 Dec; 28(5):371-83. PubMed ID: 14746341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals.
    Nambiar PR; Morton D
    Toxicol Pathol; 2013; 41(8):1058-67. PubMed ID: 23423820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice.
    Sehata S; Maejima T; Watanabe M; Ogata S; Makino T; Tanaka K; Manabe S; Takaoka M
    Toxicol Pathol; 2002; 30(3):328-38. PubMed ID: 12051550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model.
    Tennant RW; Stasiewicz S; Eastin WC; Mennear JH; Spalding JW
    Toxicol Pathol; 2001; 29 Suppl():51-9. PubMed ID: 11695562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid induction of uterine endometrial proliferative lesions in transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) given a single intraperitoneal injection of N-ethyl-N-nitrosourea.
    Watanabe T; Kashida Y; Yasuhara K; Koujitani T; Hirose M; Mitsumori K
    Cancer Lett; 2002 Dec; 188(1-2):39-46. PubMed ID: 12406546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P53+/- hemizygous knockout mouse: overview of available data.
    Storer RD; French JE; Haseman J; Hajian G; LeGrand EK; Long GG; Mixson LA; Ochoa R; Sagartz JE; Soper KA
    Toxicol Pathol; 2001; 29 Suppl():30-50. PubMed ID: 11695560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice.
    Urano K; Suzuki S; Machida K; Eguchi N; Sawa N; Kikuchi K; Hattori Y; Usui T
    J Toxicol Sci; 2007 Oct; 32(4):367-75. PubMed ID: 17965551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic alterations in HCA-induced tumors.
    Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
    Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice.
    Cho WS; Jeong J; Choi M; Park SN; Han BS; Son WC
    Arch Toxicol; 2011 Jan; 85(1):59-66. PubMed ID: 20358181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The possible mechanism of enhanced carcinogenesis induced by genotoxic carcinogens in rasH2 mice.
    Okamura M; Unami A; Moto M; Muguruma M; Ito T; Jin M; Oishi Y; Kashida Y; Mitsumori K
    Cancer Lett; 2007 Jan; 245(1-2):321-30. PubMed ID: 16530936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishing a laboratory animal model from a transgenic animal: RasH2 mice as a model for carcinogenicity studies in regulatory science.
    Urano K; Tamaoki N; Nomura T
    Vet Pathol; 2012 Jan; 49(1):16-23. PubMed ID: 22146850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.